-
Berberrubine Chloride: Mechanism-to-Assay Guide
2026-09-22
Berberrubine chloride is a multi-target research compound whose effects span IMPDH2, TrxR, GSTM2, inflammatory signaling, and urate transport. This guide presents a mechanism-to-assay framework that separates established findings from practical validation strategies.
-
NF 449: Precision P2X1 Platelet Workflows
2026-09-22
NF 449 is a high-potency purinergic receptor antagonist for separating ATP-driven P2X1 signaling from broader platelet purinergic responses. This guide translates receptor pharmacology into platelet activation studies, collagen assays, and mechanism-aware antithrombotic agent research.
-
Vasopressin Analogues: Hormones to Multitasking Peptides
2026-09-21
Glavaš and colleagues present an integrative review of vasopressin biology, receptor pharmacology, and the structural evolution of peptide and non-peptide analogues. The study clarifies how changes in stability, receptor preference, and duration of action support applications ranging from treatment of diabetes insipidus and vasoconstriction research to emerging antiviral investigations.
-
CDK4–4E-BP1 Control During Mitosis–G1
2026-09-21
The reference study identifies CDK4 as a cell-cycle-linked kinase that phosphorylates 4E-BP1 and promotes cap-dependent translation during the mitosis–G1 transition. Its time-resolved and chemoproteomic framework expands interpretation of CDK4 beyond Rb phosphorylation and provides a useful design for connecting kinase activity with translational control in cancer research.
-
CCR7–Notch1 Crosstalk in Mammary Cancer Stemness
2026-09-20
Boyle et al. showed that CCR7 signaling functionally intersects with Notch1 to sustain stem-like properties in primary MMTV-PyMT mammary cancer cells. The study supports a pathway-level model in which CCR7 activation promotes Notch1 signaling, while Notch inhibition suppresses CCR7-dependent stemness, providing a rationale for testing dual-axis intervention.
-
QX77 for Chaperone-Mediated Autophagy Research
2026-09-19
QX77 is a molecular chaperone activator for probing LAMP2A-dependent autophagy, Rab11-linked trafficking, and ES-cell fate decisions. This workflow-focused guide connects dose optimization and orthogonal readouts with the SENP2/HSPA8/FUNDC1 findings reported in bronchopulmonary dysplasia models.
-
FPH1 (BRD-6125) Hepatocyte Workflow
2026-09-18
FPH1 (BRD-6125) helps turn hepatocyte expansion into a function-first workflow by pairing proliferation measurements with albumin, CYP3A4, and AFP readouts. This guide shows how to apply the compound in primary human hepatocyte culture and iPS-derived hepatocyte assays, while placing light-regulated gene control in its proper experimental context.
-
Heparin sodium in Nanovesicle Uptake Studies
2026-09-18
Heparin sodium combines dependable anticoagulation quality control with a practical competition strategy for investigating heparan sulfate proteoglycan-dependent nanovesicle uptake. This workflow helps researchers connect anti-factor Xa and aPTT readouts with cell-entry mechanisms without confusing a mechanistic probe with a therapeutic claim.
-
PEGylated Iron Oxide Nanoparticles in the Liver
2026-09-17
This ACS Nano study systematically examines how iron oxide nanoparticle size and PEG chain length shape hepatic distribution and uptake across major liver cell populations. Its combination of 99mTc-SPECT/CT imaging with primary-cell assays challenges the assumption that Kupffer cells dominate nanoparticle clearance and identifies 2K PEG as a potentially favorable balance between circulation and reduced liver sequestration.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit Workflow
2026-09-17
Build bright, reproducible RNA probes for in situ hybridization and Northern blotting with a tunable Cy3-UTP:UTP balance. This workflow also shows how probe-quality controls can inform interpretation of tumor-selective mRNA delivery research without confusing analytical labeling with therapeutic mRNA production.
-
Alda 1: ALDH2 Activator Workflows
2026-09-16
Alda 1 enables genotype-aware ALDH2 activation workflows spanning enzyme kinetics, cardiac stress models, and aldehyde detoxification studies. This practical guide connects the latest cardiomyocyte findings with assay setup, controls, troubleshooting, and research-use limitations.
-
Toremifene Citrate: Evidence, Methods, and Limits
2026-09-16
The reference paper presents toremifene citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for postmenopausal patients with advanced hormone receptor-positive or unknown-status breast cancer. Its main contribution is a clinically oriented synthesis linking receptor pharmacology, comparative efficacy with tamoxifen, pharmacokinetics, safety monitoring, and treatment limitations relevant to breast cancer research.
-
U-73122: Phospholipase C Inhibitor Guide
2026-09-15
U-73122 is a phospholipase C inhibitor used to interrogate PLC-dependent calcium signaling, neutrophil chemotaxis, inflammation, and cancer-cell invasion. Product-reported benchmarks include an approximately 6 μM PLC-β2 IC50 and inhibition of inflammatory responses in rodent models, while peer-reviewed evidence connects U73122-sensitive PLC signaling with breast cancer invasiveness.
-
Recombinant Human IL-15 in Neuroimmune Assays
2026-09-15
Early life adversity research is revealing how developmental experience reshapes innate defensive behavior through oxytocin signaling. This thought-leadership article explains how Recombinant Human IL-15 can support rigorously controlled T-cell and NK-cell assays that add an immune dimension to translational neurobiology—without overstating what current evidence proves.
-
Thrombin B Fragment: A Decision Guide for Fibrin Assays
2026-09-14
Thrombin is a central trypsin-like serine protease, but its B chain fragment requires careful interpretation in fibrin and vascular assays. This guide distinguishes fragment identity from full-enzyme activity and translates fibrin-matrix evidence into practical experimental decisions.